|
|
 | | | |
- close
- close
- close
- close
This excerpt taken from the HWAY DEF 14A filed Dec 19, 2008. Compensation
Committee Report
The following Report of the Compensation Committee does not
constitute soliciting material and should not be deemed filed or
incorporated by reference into any other Company filing under
the Securities Act of 1933 or the Securities Exchange Act of
1934, except to the extent the Company specifically incorporates
this Report by reference therein.
The Compensation Committee has reviewed and discussed the
Compensation Discussion and Analysis with management and, based
on such review and discussions, recommended to the Board of
Directors that the Compensation Discussion and Analysis be
included in this proxy statement.
Respectfully submitted,
Jay C. Bisgard, M.D., Chairman
Alison Taunton-Rigby, Ph.D. C. Warren Neel, Ph.D. Mary Jane England, M.D. This excerpt taken from the HWAY DEF 14A filed Dec 31, 2007. Compensation
Committee Report
The following Report of the Compensation Committee does not
constitute soliciting material and should not be deemed filed or
incorporated by reference into any other Company filing under
the Securities Act of 1933 or the Securities Exchange Act of
1934, except to the extent the Company specifically incorporates
this Report by reference therein.
The Compensation Committee has reviewed and discussed the
Compensation Discussion and Analysis with management and, based
on such review and discussions, recommended to the Board of
Directors that the Compensation Discussion and Analysis be
included in this proxy statement.
Respectfully submitted,
Jay C. Bisgard, M.D., Chairman
John W. Ballantine
Alison Taunton-Rigby, Ph.D.
C. Warren Neel, Ph.D.
Mary Jane England, M.D.
| EXCERPTS ON THIS PAGE:
|
| |||||||
